CS689887A3 - Novel psychostimulating substances of the phenylalkylamine derivativestype, process of their preparation and pharmaceuticals comprising them - Google Patents

Novel psychostimulating substances of the phenylalkylamine derivativestype, process of their preparation and pharmaceuticals comprising them

Info

Publication number
CS689887A3
CS689887A3 CS876898A CS689887A CS689887A3 CS 689887 A3 CS689887 A3 CS 689887A3 CS 876898 A CS876898 A CS 876898A CS 689887 A CS689887 A CS 689887A CS 689887 A3 CS689887 A3 CS 689887A3
Authority
CS
Czechoslovakia
Prior art keywords
derivativestype
psychostimulating
phenylalkylamine
pharmaceuticals
substances
Prior art date
Application number
CS876898A
Other languages
English (en)
Other versions
CS277418B6 (en
Inventor
Jozsef Dr Knoll
Antal Dr Simay
Eva Dr Szinnyei
Eva Dr Somfai
Zoltan Dr Torok
Karoly Mozsolits
Janos Bergmann
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of CS689887A3 publication Critical patent/CS689887A3/cs
Publication of CS277418B6 publication Critical patent/CS277418B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
CS876898A 1986-09-25 1987-09-25 Novel psychostimulating substances of the phenylalkylamine derivatives type, process of their preparation and pharmaceuticalpreparation in which said erivatives are comprised CS277418B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU864101A HU207280B (en) 1986-09-25 1986-09-25 Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
CS689887A3 true CS689887A3 (en) 1992-08-12
CS277418B6 CS277418B6 (en) 1993-03-17

Family

ID=10966901

Family Applications (1)

Application Number Title Priority Date Filing Date
CS876898A CS277418B6 (en) 1986-09-25 1987-09-25 Novel psychostimulating substances of the phenylalkylamine derivatives type, process of their preparation and pharmaceuticalpreparation in which said erivatives are comprised

Country Status (21)

Country Link
US (1) US5075338A (cs)
EP (1) EP0284621B1 (cs)
KR (1) KR880701545A (cs)
AT (1) ATE117204T1 (cs)
CS (1) CS277418B6 (cs)
DD (1) DD262226A5 (cs)
DE (1) DE3751006T2 (cs)
DK (1) DK282488A (cs)
ES (1) ES2007411A6 (cs)
FI (1) FI882474A0 (cs)
GE (1) GEP19960656B (cs)
HU (1) HU207280B (cs)
IL (1) IL83905A (cs)
LT (2) LT3531B (cs)
LV (2) LV10860B (cs)
PL (1) PL151642B1 (cs)
PT (1) PT85799B (cs)
RU (1) RU2007384C1 (cs)
SU (1) SU1746882A3 (cs)
UA (3) UA11100A (cs)
WO (1) WO1988002254A1 (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430044A (en) * 1987-02-06 1995-07-04 Fisons Corporation Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
SG52662A1 (en) * 1988-08-12 1998-09-28 Astra Ab Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties
AU641394B2 (en) * 1989-06-02 1993-09-23 John Wyeth & Brother Limited Amines
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
EP1203761B1 (en) 1994-10-21 2005-01-19 Nps Pharmaceuticals, Inc. Calcium receptor-active compounds
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6033682A (en) * 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
CA2223588C (en) * 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DK0907631T3 (da) 1996-05-01 2003-09-22 Nps Pharma Inc Uorganiske ionreceptoraktive forbindelser
ES2267190T3 (es) * 1997-08-07 2007-03-01 Fujimoto Brothers Co., Ltd. Derivados de etilamina novedosos.
JP4499208B2 (ja) 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
US20050059743A1 (en) * 2000-11-01 2005-03-17 Sention, Inc. Methods for treating mild cognitive impairment and alzheimer's disease
US20030232890A1 (en) * 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
AU2002239464B2 (en) * 2000-11-01 2007-01-04 Cognition Pharmaceuticals Llc Methods and compositions for regulating memory consolidation
US20070117869A1 (en) * 2000-11-01 2007-05-24 Cognition Pharmaceuticals Llc Methods for treating coginitive impairment and improving cognition
US20030119884A1 (en) * 2000-11-01 2003-06-26 Epstein Mel H. Methods and compositions for regulating memory consolidation
WO2005000203A2 (en) 2001-10-31 2005-01-06 Sention, Inc. Methods for treating cognitive impairment and improving cognition
US7619005B2 (en) * 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
ATE411019T1 (de) * 2001-05-02 2008-10-15 Brni Neurosciences Inst Kohlensäureanhydrase-aktivatoren zur verbesserung der lern- und gedächtnisleistung
EP1935414A3 (en) * 2001-05-02 2010-08-18 Blanchette Rockefeller Neurosciences Institute Carbonic anhydrase activators for enhancig learning and memory
TW201206425A (en) * 2004-05-18 2012-02-16 Brni Neurosciences Inst Treatment of depressive disorders
WO2010121022A1 (en) 2009-04-15 2010-10-21 Research Triangle Institute Monoamine reuptake inhibitors
RU2714893C2 (ru) 2014-12-05 2020-02-20 Земмельвайс Юнивёрсити Арилалкиламиновые соединения для применения для профилактики или лечения рака

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US485926A (en) 1892-11-08 Field
DE767263C (de) * 1937-10-03 1952-03-31 Theodor H Temmler Verfahren zur Herstellung von ª‰-Aralkylaminen
DE893341C (de) * 1950-08-23 1953-10-15 Troponwerke Dinklage & Co Verfahren zur Herstellung von N-Aralkyl-ª‰-phenyl-isopropylaminen
US2797242A (en) * 1953-08-11 1957-06-25 Parke Davis & Co Substituted alpha-benzylphenethylamines and methods for producing the same
DE227447C (cs) 1955-03-23 1910-10-21
DE1210873B (de) * 1959-03-18 1966-02-17 Hoffmann La Roche Verfahren zur Herstellung von Halogenalkylaminen
US3044932A (en) * 1960-02-24 1962-07-17 Upjohn Co Appetite suppressant drugs
DE1133395B (de) * 1960-11-12 1962-07-19 Hoechst Ag Verfahren zur Herstellung von herz- und kreislaufwirksamen Phenylalkylaminen
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
GB1031425A (en) * 1962-03-30 1966-06-02 Chinoin Gyogyszer Es Vegyeszet New aralkylamines and their preparation
FR1478311A (fr) * 1963-10-18 1967-04-28 Koninklijke Pharma Fab Nv Procédé de préparation d'aminoalcanes et produits en résultant
GB1218135A (en) * 1967-07-28 1971-01-06 Abbott Lab Substituted phenethylamine derivatives
DE2143204C3 (de) * 1971-08-28 1979-09-27 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt N-Fluoralkyl-phenylisopropylamin-Derivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
US4025624A (en) * 1975-11-18 1977-05-24 A. H. Robins Company, Incorporated Phenylalkylamines and phenylalkylureas in combinations to suppress gastric bleeding in aspirin therapy
US4404222A (en) * 1980-08-25 1983-09-13 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby
DD145599A1 (de) * 1979-08-23 1980-12-24 Roswitha Toepfer Mittel zur regulierung des pflanzenwachstums

Also Published As

Publication number Publication date
LV10709A (lv) 1995-06-20
HU207280B (en) 1993-03-29
DD262226A5 (de) 1988-11-23
FI882474A7 (fi) 1988-05-25
ATE117204T1 (de) 1995-02-15
CS277418B6 (en) 1993-03-17
UA19808A (uk) 1997-12-25
FI882474A0 (fi) 1988-05-25
LV10709B (en) 1995-12-20
SU1746882A3 (ru) 1992-07-07
PL151642B1 (en) 1990-09-28
EP0284621A1 (en) 1988-10-05
WO1988002254A1 (en) 1988-04-07
US5075338A (en) 1991-12-24
DE3751006D1 (de) 1995-03-02
DE3751006T2 (de) 1995-05-24
PT85799B (pt) 1990-08-31
LTIP879A (en) 1995-03-27
LT3531B (en) 1995-11-27
PL267913A1 (en) 1989-03-06
LTIP878A (en) 1995-03-27
PT85799A (en) 1987-10-01
GEP19960656B (en) 1996-12-24
KR880701545A (ko) 1988-11-03
LV10860B (en) 1996-04-20
IL83905A (en) 1993-07-08
RU2007384C1 (ru) 1994-02-15
UA19171A (uk) 1997-12-25
DK282488D0 (da) 1988-05-24
EP0284621B1 (en) 1995-01-18
LT3530B (en) 1995-11-27
HUT45962A (en) 1988-09-28
ES2007411A6 (es) 1989-06-16
LV10860A (lv) 1995-10-20
UA11100A (uk) 1996-12-25
DK282488A (da) 1988-05-24

Similar Documents

Publication Publication Date Title
HUT45962A (en) Process for producing phenyl-alkyl-amines and pharmaceutical compositions containing them
HUT45247A (en) Process for producing thiazolidinediones with hypolycaemic effect and pharmaceutical compositions comprising the same
FR2435248A1 (fr) Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique
DE69523350D1 (de) Behandlung von hyperproliferativen Gefässerkrankungen
PT81674A (en) Process for the preparation of pharmaceutically active n-acilated of l-tryptophan derivatives of pharmaceutical compositions and of a pharmaceutical product containing them useful for human pain relief
ES539123A0 (es) Un compuesto de 3-indolcarboxamida
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
TNSN92017A1 (fr) Procede de preparation, d'un derive de benzothiazole, et d'une composition pharmaceutique le contenant et procede de traitement en comportant application
MY104521A (en) Treatment of depression.
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
GB8706662D0 (en) Anti-arrhythmia agents
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
HUT37439A (en) Process for production of derivatives of phosphorilized glucose-amidcarbamide-carbamate and tiocarbamate and medical preparatives consisting of such substances
DE69403242D1 (de) Cyathane Derivate und diese enthaltende Nervenwachstumsfaktor Produktion Stimulatoren und antimikrobielle Mittel
FR2604707B1 (fr) Procede de preparation d'un compose therapeutique actif
KR900000383A (ko) 신규 화합물
FR2648814B1 (fr) L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique
EP1103255A4 (en) CULTIVATION AND FOOD PROCESS
KR950704322A (ko) 스피로푸라논 유도체 및 그의 신경변성 질환 치료 용도(Spirofuranone Derivatives and Their Use in the Treatment of Neurodegenerative Disorders)
ATE132748T1 (de) Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres